1.
Personalized 177Lu-octreotate peptide receptor radionuclide therapy of neuroendocrine tumours: a simulation study
by Del Prete, Michela
European journal of nuclear medicine and molecular imaging, 2017-03-31, Vol.44 (9), p.1490-1500
2.
Three drugs vs two drugs first-line chemotherapy regimen in advanced gastric cancer patients: a retrospective analysis
by Bittoni, Alessandro
SpringerPlus, 2015-12-01, Vol.4 (1), p.743-743
3.
Selected news from the 2014 Genitourinary Cancers Symposium: translating novel strategies into clinical practice
by Bianconi, Maristella
Future oncology (London, England), 2014-11-01, Vol.10 (14), p.2103-2106
4.
Personalized 177Lu-octreotate peptide receptor radionuclide therapy of neuroendocrine tumours: initial results from the P-PRRT trial
by Del Prete, Michela
European journal of nuclear medicine and molecular imaging, 2018-11-30, Vol.46 (3), p.728-742
5.
Role of beta 4 integrin in HER-3-negative, K-RAS wild-type metastatic colorectal tumors receiving cetuximab
by Scartozzi, Mario
Future oncology (London, England), 2013-08-01, Vol.9 (8), p.1207-1214
6.
Role of β4 integrin in HER-3-negative, K-RAS wild-type metastatic colorectal tumors receiving cetuximab
by Scartozzi, Mario
Future oncology (London, England), 2013-08, Vol.9 (8), p.1207-1214
7.
Personalized 177 Lu-octreotate peptide receptor radionuclide therapy of neuroendocrine tumours: initial results from the P-PRRT trial
by Del Prete, Michela
European journal of nuclear medicine and molecular imaging, 2019-03, Vol.46 (3), p.728
8.
Personalized 177.sup.Lu-octreotate peptide receptor radionuclide therapy of neuroendocrine tumours: a simulation study
by Del Prete, Michela
European journal of nuclear medicine and molecular imaging, 2017-08-01, Vol.44 (9), p.1490
9.
Personalized 177.sup.Lu-octreotate peptide receptor radionuclide therapy of neuroendocrine tumours: initial results from the P-PRRT trial
by Del Prete, Michela
European journal of nuclear medicine and molecular imaging, 2019-03-01, Vol.46 (3), p.728
10.
Personalized 177 Lu-octreotate peptide receptor radionuclide therapy of neuroendocrine tumours: a simulation study
by Del Prete, Michela
European journal of nuclear medicine and molecular imaging, 2017-08, Vol.44 (9), p.1490
11.
Role of 4 integrin in
by Scartozzi, Mario
Future oncology (London, England), 2013-08-01, Vol.9 (8), p.1207-1214
12.
Role of [beta]4 integrin in HER-3-negative, K-RAS wild-type metastatic colorectal tumors receiving cetuximab
by Mario Scartozzi
Future oncology (London, England), 2013-08-01, Vol.9 (8), p.1207
13.
Multiple ovarian cysts in a young girl with severe hypothyroidism
by Panico, Annalisa
Thyroid (New York, N.Y.), 2007-12, Vol.17 (12), p.1289-1293
14.
Maternal stress and depressive symptoms associated with quality of developmental care in 25 Italian Neonatal Intensive Care Units: A cross sectional observational study
by Montirosso, Rosario
International journal of nursing studies, 2014-07, Vol.51 (7), p.994-1002
